Anticoagulation for Nonvalvular Atrial Fibrillation: Effects of Type of Practice on Physicians’ Self-Reported Behavior

Anonymous: Cardiogenic brain embolism. Cerebral Embolism Task Force. Arch Neurol 1986;43:71–84. [Review]. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators (published erratum appears in NEJM 1993 Jan 14;328:148) (see comments.) NEJM 1992;327:1406–1412. Petersen, 1989, Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation, Lancet, 1, 175, 10.1016/S0140-6736(89)91200-2 McCrory, 1995, Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly, Arch Intern Med, 155, 277, 10.1001/archinte.1995.00430030071008 Kutner, 1991, Physicians’ attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation, Arch Intern Med, 151, 1950, 10.1001/archinte.1991.00400100038006 Stafford, 1996, National patterns of warfarin use in atrial fibrillation, Arch Intern Med, 156, 2537, 10.1001/archinte.1996.00440210043004 Anonymous: Cardiogenic brain embolism. The second report of the cerebral embolism task force (published erratum appears in Arch Neurol 1989 Oct;46:1079) (see comments.) Arch Neurol 1989;46:727–743. [Review]. King, 1995, Atrial fibrillation in the elderly, Br J Clin Pract, 49, 123, 10.1111/j.1742-1241.1995.tb09917.x Lin, 1995, Newly diagnosed atrial fibrillation and acute stroke, Stroke, 26, 1527, 10.1161/01.STR.26.9.1527 Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke, Stroke, 22, 983, 10.1161/01.STR.22.8.983 Wolf, 1987, Atrial fibrillation, Arch Intern Med, 147, 1561, 10.1001/archinte.1987.00370090041008 Anonymous: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Atrial Fibrillation Investigators: Atrial Fibrillation, Aspirin, Anticoagulation Study; Boston Area Anticoagulation Trial for Atrial Fibrillation Study; Canadian Atrial Fibrillation Anticoagulation Study; Stroke Prevention in Atrial Fibrillation Study; Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Study. Arch Intern Med 1994;154:1449–1457. Wilson, 1985, Chronic atrial fibrillation in the elderly, J Am Geriatr Soc, 33, 298, 10.1111/j.1532-5415.1985.tb07121.x Hylek, 1994, Risk factors for intracranial hemorrhage in outpatients taking warfarin, Ann Intern Med, 120, 897, 10.7326/0003-4819-120-11-199406010-00001 Fihn, 1993, Risk factors for complications of chronic anticoagulation. A multicenter study, Ann Intern Med, 118, 511, 10.7326/0003-4819-118-7-199304010-00005